Foundation Medicine has appointed Steven Kafka to chief business officer, a newly created position. He joins the company from Aileron Therapeutics, where he served as chief operating officer and chief financial officer. Previously, he was vice president of finance for Infinity Pharmaceuticals and senior director of finance at Millennium Pharmaceuticals. He holds a BA from Stanford University and a PhD from Harvard University.
Christopher McGuigan has been appointed to serve on Trovagene's board of directors.
McGuigan has been head of medicinal chemistry at Cardiff University and a professor at the Welsh School of Pharmacy since 1995, and last year he was appointed pro vice chancellor at the school. He also is a member of the editorial board for the Journal of Molecular Pharmaceutics and a former president of the International Society for Antiviral Research.